European Union regulatory law expert  Ulf Grundmann joins the US firm as a partner in the firm’s FDA and life sciences practice. Grundmann focuses on European regulatory work in the pharmaceutical, medical device and food industries, and advises European and U.S. companies on related litigation, intellectual property and unfair competition matters. He is a lecturer at the Frankfurt School of Finance and Management and the Deutsche Anwalts Akademie. He is a contributing author of the 2012 Guide to EU Pharmaceutical Regulatory Law published by Wolters Kluwer.

Further capacity

“Ulf’s international regulatory expertise adds a further dimension to our capabilities of serving the global regulatory needs of our pharmaceutical, medical device, and food clients around the world,” said Mark S. Brown, leader of King & Spalding’s FDA & Life Sciences practice. “Ulf is a top-quality EU regulatory expert. We are pleased he has joined our firm, and we look forward to working shoulder-to-shoulder with him to serve our ever-expanding life science and food industry clients’ European regulatory needs.”

King & Spalding’s FDA & Life Sciences practice comprises more than 30 lawyers and non-attorney professionals, many of whom have served on staff at the FDA. The practice provides counseling on a full array of matters involving medical devices, pharmaceuticals, over-the-counter drugs, biologics, biotechnology, food, animal drugs and consumer products.